Predominant contribution of L-type amino acid transporter to 4-borono-2-18F-fluoro-phenylalanine uptake in human glioblastoma cells

Nuclear Medicine and Biology

Volumn 40, Issue 5, 2013, Pages 625-629

  Yoshimoto, Mitsuyoshi ^a   Kurihara, Hiroaki ^b   Honda, Natsuki ^b   Kawai, Keiichi ^c   Ohe, Kazuyo ^c   Fujii, Hirofumi ^a   Itami, Jun ^b   Arai, Yasuaki ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

18F FBPA; Amino acid transporters; BNCT; Glioblastoma; System L

Indexed keywords

4 BORONO 2 FLUOROPHENYLALANINE F 18; 4 BORONOPHENYLALANINE; AMINO ACID TRANSPORTER; L TYPE AMINO ACID TRANSPORTER; METHIONINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CORRELATION ANALYSIS; DRUG TRANSPORT; DRUG UPTAKE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEUTRON CAPTURE THERAPY; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SERUM; TUMOR CELL LINE;

AMINO ACID TRANSPORT SYSTEMS; BIOLOGICAL TRANSPORT; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; METHIONINE; PHENYLALANINE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84878170393     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.02.010     Document Type: Article

References (29)

1. Barth R.F., Coderre J.A., Vicente M.G., Blue T.E. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 2005, 11:3987-4002.
2. Kankaanranta L., Seppala T., Koivunoro H., Valimaki P., Beule A., Collan J., et al. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a phase I study. Int J Radiat Oncol Biol Phys 2011, 80:369-376.
3. Kawabata S., Miyatake S., Kuroiwa T., Yokoyama K., Doi A., Iida K., et al. Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res 2009, 50:51-60.
4. Soloway A.H., Tjarks W., Barnum B.A., Rong F.G., Barth R.F., Codogni I.M., et al. The chemistry of neutron capture therapy. Chem Rev 1998, 98:1515-1562.
5. Ishiwata K., Ido T., Honda C., Kawamura M., Ichihashi M., Mishima Y. 4-Borono-2-[18 F]fluoro-D, L-phenylalanine: a possible tracer for melanoma diagnosis with PET. Int J Rad Appl Instrum B 1992, 19:311-318.
6. Ishiwata K., Ido T., Kawamura M., Kubota K., Ichihashi M., Mishima Y. 4-Borono-2-[18 F]fluoro-D, L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. Int J Rad Appl Instrum B 1991, 18:745-751.
7. Imahori Y., Ueda S., Ohmori Y., Sakae K., Kusuki T., Kobayashi T., et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Clin Cancer Res 1998, 4:1825-1832.
8. Imahori Y., Ueda S., Ohmori Y., Sakae K., Kusuki T., Kobayashi T., et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res 1998, 4:1833-1841.
9. Babu E., Kanai Y., Chairoungdua A., Kim D.K., Iribe Y., Tangtrongsup S., et al. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem 2003, 278:43838-43845.
10. Bodoy S., Martin L., Zorzano A., Palacin M., Estevez R., Bertran J. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem 2005, 280:12002-12011.
11. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998, 273:23629-23632.
12. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999, 274:19745-19751.
13. Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T., et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 2001, 1514:291-302.
14. Fuchs B.C., Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin Cancer Biol 2005, 15:254-266.
15. Detta A., Cruickshank G.S. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res 2009, 69:2126-2132.
16. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998, 50:1316-1322.
17. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2008, 10:1-18.
18. 11C-labeled L- and D-methionine in human-derived tumor cells. Nucl Med Biol 2012, 39:1213-1218.
19. Langen K.J., Muhlensiepen H., Holschbach M., Hautzel H., Jansen P., Coenen H.H. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. J Nucl Med 2000, 41:1250-1255.
20. Ishiwata K., Ido T., Mejia A.A., Ichihashi M., Mishima Y. Synthesis and radiation dosimetry of 4-borono-2-[18 F]fluoro-D, L-phenylalanine: a target compound for PET and boron neutron capture therapy. Int J Rad Appl Instrum A 1991, 42:325-328.
21. Okudaira H., Shikano N., Nishii R., Miyagi T., Yoshimoto M., Kobayashi M., et al. Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med 2011, 52:822-829.
22. Kersemans V., Cornelissen B., Kersemans K., Bauwens M., Achten E., Dierckx R.A., et al. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. J Nucl Med 2005, 46:532-539.
23. 125I]-2- iodo-L-phenylalanine in a R1M rhabdomyosarcoma cell model as a new potential tumor tracer for SPECT. Nucl Med Biol 2004, 31:739-746.
24. Haase C., Bergmann R., Fuechtner F., Hoepping A., Pietzsch J. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med 2007, 48:2063-2071.
25. Soriano-Garcia J.F., Torras-Llort M., Ferrer R., Moreto M. Multiple pathways for L-methionine transport in brush-border membrane vesicles from chicken jejunum. J Physiol 1998, 509(Pt 2):527-539.
26. Shotwell M.A., Jayme D.W., Kilberg M.S., Oxender D.L. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981, 256:5422-5427.
27. Hatanaka T., Huang W., Wang H., Sugawara M., Prasad P.D., Leibach F.H., et al. Primary structure, functional characteristics and tissue expression pattern of human ATA2, a subtype of amino acid transport system A. Biochim Biophys Acta 2000, 1467:1-6.
28. +-dependent neutral amino acid transporter. J Biol Chem 1996, 271:14883-14890.
29. Wiriyasermkul P., Nagamori S., Tominaga H., Oriuchi N., Kaira K., Nakao H., et al. Transport of 3-fluoro-L-alpha-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET. J Nucl Med 2012, 53:1253-1261.